7113 (Docusate 250 mg)
Pill imprint 7113 has been identified as Docusate sodium 250 mg.
Docusate is used in the treatment of constipation and belongs to the drug class laxatives. FDA has not classified the drug for risk during pregnancy. Docusate 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
Docusate sodium
- Imprint:
- 7113
- Strength:
- 250 mg
- Color:
- Red
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- Laxatives
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00536-3757
- Inactive Ingredients:
- FD&C Red No. 40
FD&C Yellow No. 6
gelatin
glycerin
polyethylene glycol
propylene glycol
water
sorbitol
More about docusate
Consumer resources
- Other brands: Colace, Dulcolax Stool Softener, Doc-Q-Lace, Docu, More (22) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
